Sakamoto T - Search Results

1

Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors.

Hada T, Miyamoto M, Ishibashi H, Kawauchi H, Soyama H, Matsuura H, Sakamoto T, Kakimoto S, Aoyama T, Iwahashi H, Suzuki R, Tsuda H, Takano M. Hada T, et al. Among authors: sakamoto t. In Vivo. 2020 May-Jun;34(3):1341-1346. doi: 10.21873/invivo.11911. In Vivo. 2020. PMID: 32354928 Free PMC article.

2

Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma.

Matuura H, Miyamoto M, Takano M, Soyama H, Aoyama T, Yoshikawa T, Kato K, Sakamoto T, Kuwahara M, Takasaki K, Ishibashi H, Iwahashi H, Tsuda H, Furuya K. Matuura H, et al. Among authors: sakamoto t. Anticancer Res. 2018 Feb;38(2):717-722. doi: 10.21873/anticanres.12277. Anticancer Res. 2018. PMID: 29374695

3

A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas.

Soyama H, Miyamoto M, Takano M, Iwahashi H, Kato K, Sakamoto T, Kuwahara M, Ishibashi H, Matuura H, Yoshikawa T, Aoyama T, Tsuda H, Furuya K. Soyama H, et al. Among authors: sakamoto t. In Vivo. 2018 May-Jun;32(3):597-602. doi: 10.21873/invivo.11281. In Vivo. 2018. PMID: 29695566 Free PMC article.

4

Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature.

Hada T, Miyamoto M, Ishibashi H, Matsuura H, Sakamoto T, Kakimoto S, Iwahashi H, Tsuda H, Takano M. Hada T, et al. Among authors: sakamoto t. J Ovarian Res. 2021 Feb 14;14(1):33. doi: 10.1186/s13048-021-00783-3. J Ovarian Res. 2021. PMID: 33583413 Free PMC article. Review.

5

Hada T, Miyamoto M, Ishibashi H, Matsuura H, Sakamoto T, Kakimoto S, Iwahashi H, Suzuki R, Sato K, Tsuda H, Takano M. Hada T, et al. Among authors: sakamoto t. Medicine (Baltimore). 2021 Aug 13;100(32):e26895. doi: 10.1097/MD.0000000000026895. Medicine (Baltimore). 2021. PMID: 34397915 Free PMC article.

6

Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.

Soyama H, Miyamoto M, Takano M, Aoyama T, Matsuura H, Sakamoto T, Takasaki K, Kuwahara M, Kato K, Yoshikawa T, Iwahashi H, Tsuda H, Furuya K. Soyama H, et al. Among authors: sakamoto t. Med Oncol. 2017 Nov 22;34(12):201. doi: 10.1007/s12032-017-1058-3. Med Oncol. 2017. PMID: 29168038

7

Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis.

Takasaki K, Miyamoto M, Takano M, Soyama H, Aoyama T, Matsuura H, Kato K, Sakamoto T, Kuwahara M, Iwahashi H, Ishibashi H, Yoshikawa T, Furuya K. Takasaki K, et al. Among authors: sakamoto t. Cancer Chemother Pharmacol. 2018 May;81(5):809-814. doi: 10.1007/s00280-018-3552-5. Epub 2018 Mar 2. Cancer Chemother Pharmacol. 2018. PMID: 29500481

8

Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine.

Soyama H, Miyamoto M, Matsuura H, Iwahashi H, Kakimoto S, Ishibashi H, Sakamoto T, Hada T, Suminokura J, Takano M. Soyama H, et al. Among authors: sakamoto t. Cancer Chemother Pharmacol. 2020 May;85(5):941-947. doi: 10.1007/s00280-020-04070-8. Epub 2020 Apr 11. Cancer Chemother Pharmacol. 2020. PMID: 32279102

9

Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma.

Kakimoto S, Miyamoto M, Einama T, Matsuura H, Iwahashi H, Ishibashi H, Sakamoto T, Hada T, Takano M. Kakimoto S, et al. Among authors: sakamoto t. Pathol Oncol Res. 2020 Oct;26(4):2299-2306. doi: 10.1007/s12253-020-00823-1. Epub 2020 May 28. Pathol Oncol Res. 2020. PMID: 32468249 Free article.

10

The use of magnetic resonance imaging to predict placenta previa with placenta accreta spectrum.

Ishibashi H, Miyamoto M, Shinmoto H, Soga S, Matsuura H, Kakimoto S, Iwahashi H, Sakamoto T, Hada T, Suzuki R, Takano M. Ishibashi H, et al. Among authors: sakamoto t. Acta Obstet Gynecol Scand. 2020 Dec;99(12):1657-1665. doi: 10.1111/aogs.13937. Epub 2020 Jul 23. Acta Obstet Gynecol Scand. 2020. PMID: 32542670 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,391 results

Search Page

Filters